Preclinical selection of new anthracyclines.
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D002462:Cell Membrane / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D004247:DNA / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004351:Drug Resistance; D006321:Heart / Q000187:drug effects; D006801:Humans; D008657:Metabolic Clearance Rate; D051379:Mice; D008954:Models, Biological; D009374:Neoplasms, Experimental / Q000188:drug therapy; D014411:Neoplastic Stem Cells / Q000187:drug effects; D013329:Structure-Activity Relationship
D000903:Antibiotics, Antineoplastic; D004247:DNA